Actively Recruiting

Early Phase 1
Age: 18Years - 50Years
FEMALE
Healthy Volunteers
NCT06547619

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

Led by Anna Stanhewicz, PhD · Updated on 2025-12-09

40

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined. The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.

CONDITIONS

Official Title

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

Who Can Participate

Age: 18Years - 50Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • History of pregnancy within 5 years of the study visit
  • Had either a healthy pregnancy or gestational diabetes diagnosed by an obstetrician and confirmed by American College of Obstetricians and Gynecologists criteria
Not Eligible

You will not qualify if you...

  • Presence of skin diseases
  • Current use of tobacco or electronic cigarettes/vape pens
  • Diagnosed or suspected liver or metabolic diseases including diabetes
  • Use of statins or other cholesterol-lowering medications
  • Current use of antihypertensive medications
  • History of preeclampsia or gestational hypertension
  • Current hypertension
  • Current pregnancy
  • Body mass index less than 18.5 kg/m2
  • Allergy to materials used during the experiment such as latex or allergies to study drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

Loading map...

Research Team

A

Anna Reid-Stanhewicz, PHD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here